PS Ratio
11.30
+0.15+1.35%
Sat, 22 Feb 2025 00:59:29 GMT
Summary
- As of February 22, 2025, VRTX price to sales ratio is 11.30, with a rise of +0.15 (+1.35%) during the most recent trading day.
- Over the past year, VRTX PS ratio has increased by +0.35 (+3.20%).
- VRTX PS ratio is now -86.98% below its all-time high of 86.82.
Performance
VRTX PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
VRTX PS Ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | +1.4% | +1.4% | +1.4% | +3.7% |
| 1 m1 month | +13.3% | +13.4% | +13.3% | - |
| 3 m3 months | +3.6% | +7.7% | +7.4% | +3.7% |
| 6 m6 months | -7.1% | -0.4% | -0.9% | - |
| ytdytd | +22.4% | +22.5% | +22.4% | - |
| 1 y1 year | +3.2% | +15.9% | +15.3% | +11.7% |
| 5 y5 years | -26.3% | +96.9% | +95.0% | +26.7% |
VRTX PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.2% | 9.97 | +13.3% | |
| 3 m | 3-month | 11.56 | -2.3% | 9.23 | +22.4% |
| 6 m | 6-month | 12.60 | -10.3% | 9.23 | +22.4% |
| 1 y | 1-year | 12.72 | -11.2% | 9.23 | +22.4% |
| 3 y | 3-year | 12.72 | -11.2% | 7.56 | +49.5% |
| 5 y | 5-year | 15.91 | -29.0% | 6.36 | +77.7% |
| alltime | all time | 86.82 | -87.0% | 4.21 | +168.4% |
Vertex Pharmaceuticals Incorporated PS Ratio History
| Date | Value |
|---|---|
| 2025 | 11.30(+22.4%) |
| 2024 | 9.23(-13.4%) |
| 2023 | 10.66(+28.3%) |
| 2022 | 8.31(+12.6%) |
| 2021 | 7.38(-25.5%) |
| 2020 | 9.90(-27.3%) |
| 2019 | 13.62(-1.8%) |
| 2018 | 13.87(-9.0%) |
| 2017 | 15.25(+41.9%) |
| 2016 | 10.75(-64.2%) |
| 2015 | 30.02(-39.3%) |
| 2014 | 49.48(+245.3%) |
| 2013 | 14.33(+140.4%) |
| 2012 | 5.96(+20.9%) |
| 2011 | 4.93(-90.1%) |
| 2010 | 49.73(-40.9%) |
| 2009 | 84.09(+222.8%) |
| Date | Value |
|---|---|
| 2008 | 26.05(+68.0%) |
| 2007 | 15.51(-28.9%) |
| 2006 | 21.81(+17.3%) |
| 2005 | 18.60(+123.8%) |
| 2004 | 8.31(-20.4%) |
| 2003 | 10.44(-18.2%) |
| 2002 | 12.77(-65.3%) |
| 2001 | 36.77(+32.7%) |
| 2000 | 27.70(+56.0%) |
| 1999 | 17.76(-40.7%) |
| 1998 | 29.94(+57.6%) |
| 1997 | 19.00(-58.4%) |
| 1996 | 45.65(+120.1%) |
| 1995 | 20.74(+57.7%) |
| 1994 | 13.15(+62.9%) |
| 1993 | 8.07(-73.5%) |
| 1992 | 30.44(-44.2%) |
| 1991 | 54.57 |
FAQ
- What is Vertex Pharmaceuticals Incorporated price to sales ratio?
- What is the all time high PS ratio for Vertex Pharmaceuticals Incorporated?
- What is VRTX price to sales ratio year-to-date change?
- What is Vertex Pharmaceuticals Incorporated PS ratio year-on-year change?
What is Vertex Pharmaceuticals Incorporated price to sales ratio?
The current PS ratio of VRTX is 11.30
What is the all time high PS ratio for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high price to sales ratio is 86.82
What is VRTX price to sales ratio year-to-date change?
Vertex Pharmaceuticals Incorporated price to sales ratio has changed by +2.07 (+22.43%) since the beginning of the year
What is Vertex Pharmaceuticals Incorporated PS ratio year-on-year change?
Over the past year, VRTX price to sales ratio has changed by +0.35 (+3.20%)